Diabeto-Cardiology 2e-A Companion to Braunwald’s Heart Disease > Cardiology

Part of the renowned Braunwald family of references, Diabeto-Cardiology, 2nd Edition, provides today’s clinicians with clear, authoritative guidance on the complex challenges of providing care to patients with cardiovascular and diabetes co-morbidities. Drs. Darren K. McGuire and Nikolaus Marx, along with a leading team of experts in cardiology and diabetes, address both the foundational aspects and clinical implications for this growing number of patients, including recent breakthrough therapies and new medications that have contributed to newer and more effective treatments and improved patient outcomes. From cover to cover, this second edition offers reliable and current point-of-care coverage of the interwoven care needs of patients with these complex co-morbidities, making it an ideal resource for practitioners at all levels of experience.

Key Features

• Discusses cutting-edge therapeutic approaches to the medical care of cardiology patients with diabetes, combining coverage of the latest understanding of the complex relationship between diabetes and cardiovascular disease with recent clinical advances.
• Offers a contemporary, clinical focus based on a new understanding of underlying pathologies, as well as application of evidence from clinical trials that have dramatically changed treatment and affected both cardiology and endocrinology practice.
• Includes state-of-the-art coverage of antihyperglycemic medications that have demonstrated efficacy to reduce risk for atherosclerotic cardiovascular disease, heart failure, and kidney disease progression, that have affected a revolution of therapy in both cardiology and endocrinology.
• Features a practical, concise presentation with a focus on actionable clinical content, including new Clinical Practice Points and Take Home Summaries.
• An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.

Section 1 Diabetes Mellitus
1. Definition and Epidemiology of Type 2 Diabetes Mellitus
2. Insulin Resistance: Pathophysiology, Molecular Mechanisms, Genetic Insights
3. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
4. Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes　
5. Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease

Section 2 Cardiovascular Complications of Type 2 Diabetes
6. Atherosclerosis in Patients with Type 2 Diabetes: Epidemiology
7. Pathology and Vascular Biology of Atherosclerosis in Patients with Type 2 Diabetes: Inflammation, Dyslipidemia, Hypercoagulability, Endothelial Dysfunction, and Inflammation
8. Risk Stratification Among Patients with Type 2 Diabetes with or at Risk for Atherosclerotic Cardiovascular Disease
9. Epidemiology and Pathophysiology of Heart Failure with Preserved and with Reduced Ejection Fraction in Patients with Type 2 Diabetes

Section 3 Effects of Antihyperglycemic Therapies for Type 2 Diabetes on Cardiovascular and Kidney Outcomes
10. Effect of Acute and Chronic Glucose Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
11. Regulatory Approach to Medications for Type 2 Diabetes: Past, Present and Future
12. Cardiovascular and Kidney Effects of Sodium Glucose Co-transporter Inhibitors
13. Cardiovascular and Kidney Effects of Glucagon-like Peptide 1 Receptor Agonists
14. Antihyperglycemic Medications with Proven Cardiovascular Safety
15. Prevention of Heart Failure in Patients with Type 2 Diabetes
16. Treatment of Patients with Reduced and with Preserved Ejection Fraction Heart Failure in Patients with Type 2 Diabetes

Section 4 Management of Coronary Heart Disease Risk, Chronic and Acute Coronary Syndromes in Patients with Type 2 Diabetes
17. Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
18. Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
19. Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
20. Effect of Antiplatelet and Anticoagulant Therapies on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
21. Therapeutic Implications of Type 2 Diabetes for Patients Undergoing Percutaneous or Surgical Coronary Revascularization
22. Epidemiology of Acute Coronary Syndromes in Patients with Type 2 Diabetes
23. Antiplatelet and Anticoagulant Therapy in Patients with Type 2 Diabetes with Acute Coronary Syndromes and/or Percutaneous Coronary Intervention

Section 5 Other Cardiovascular Considerations Associated with Type 2 Diabetes
24. Peripheral Artery Disease in Patients with Type 2 Diabetes
25. Cerebrovascular Disease in Patients with Type 2 Diabetes
26. Atrial Fibrillation in Patients with Type 2 Diabetes
27. Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients with Type 2 Diabetes
28. Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Women, Race/Ethnic Minorities, and the Elderly
29. The Quality Chasm - Type 2 Diabetes